While current evidence suggests that STIC could act as a precursor for ovarian carcinoma in high-risk women with inherited BRCA1 or BRCA2 mutations, the clinical significance of STIC is not as well-defined in women from the general population, where 85–90% of all HGSC originate [31]. Here, BRCA1 is linked to ovarian carcinoma.